NCT05836324 2025-12-18
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
Incyte Corporation
Phase 1 Recruiting
Incyte Corporation
Providence Health & Services
SCRI Development Innovations, LLC
AstraZeneca